CAS NO: | 70024-40-7 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | Terazosin hydrochloride dihydrate is a quinazoline derivative and a competitive and orally activeα1-adrenoceptorantagonist. Terazosin hydrochloride dihydrate works by relaxing blood vessels and the opening of the bladder. Terazosin hydrochloride dihydrate has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment[1][2][3]. | ||||||||||||||||
IC50& Target | α1-adrenoceptor[1] | ||||||||||||||||
体外研究 (In Vitro) | Terazosin does not discriminate cloned α1-adrenoceptor subtypes transiently expressed in COS cells[1]. | ||||||||||||||||
体内研究 (In Vivo) | Terazosin can be used to promote stone discharge in treatment of ureteral stones. Terazosin is reportedly safe and effective in treatment of distal ureteral stones, especially stones >5 mm[3]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 459.92 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C19H30ClN5O6 | ||||||||||||||||
CAS 号 | 70024-40-7 | ||||||||||||||||
中文名称 | 盐酸特拉唑嗪(二水合物) | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 31.25 mg/mL(67.95 mM;Need ultrasonic) H2O : 12.5 mg/mL(27.18 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|